EPHA2 and neoplasm: Conversely, inhibiting EphA2 expression using small interfering RNA (siRNA) has been shown to impede the malignant progression of pancreatic, ovarian, and mesothelioma tumor cell lines, underscoring the pivotal role of EphA2 in tumor development [48].